All posts by: Michael Zand

About Michael Zand

FDA OKs Merck drug that prevents infection post-stem cell transplant – Reuters

Continue reading

2017-11-09 NEWS

FDA OKs Merck drug that prevents infection post-stem cell transplant
Reuters
(Reuters) – Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. Merck said the drug, which is expected to be …

and more »

Continue reading

2017-11-09 NEWS

FDA OKs Merck drug to stop infection post-stem cell transplant
Reuters
Nov 9 (Reuters) – Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. The drug was approved to prevent …

and more »

Continue reading

2017-11-09 NEWS

Genetic Literacy Project

CRISPR at home: Is it really that easy to hack DNA?
Genetic Literacy Project
I am not a DIY scientist, much less a professional scientist. You won’t find me swabbing my cheek cells for DNA or tinkering with yeast in a lab on the weekend. But I wondered: Is CRISPR so easy that even amateurs like me can make meaningful

Continue reading

2017-11-09 NEWS

Genetic Literacy Project

CRISPR at home: Is it really that easy to hack DNA?
Genetic Literacy Project
I am not a DIY scientist, much less a professional scientist. You won’t find me swabbing my cheek cells for DNA or tinkering with yeast in a lab on the weekend. But I wondered: Is CRISPR so easy that even amateurs like me can make meaningful

Continue reading

2017-11-09 NEWS

FDA OKs Merck drug to stop infection post-stem cell transplant
Reuters
Nov 9 (Reuters) – Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. The drug was approved to prevent …

and more »

Continue reading

2017-11-09 NEWS

FDA OKs Merck drug to stop infection post-stem cell transplant
Reuters
Nov 9 (Reuters) – Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. The drug was approved to prevent …

and more »